Article

Pharmacy Times® Expands Its Strategic Alliance Partnership Program With the Addition of Yale Cancer Center

Pharmacy Times®, the leading multimedia resource for pharmacy professionals, is excited to announce Yale Cancer Center is now part of its Strategic Alliance Partnership program.

Pharmacy Times®, the leading multimedia resource for pharmacy professionals, is excited to announce Yale Cancer Center is now part of its Strategic Alliance Partnership (SAP) program.

“As a world leader in cancer research and education, Yale Cancer Center is devoted to training the next generation of cancer care leaders,” said Gil Hernandez, vice president of Pharmacy & Healthcare Communications, LLC, publisher of Pharmacy Times®. “We look forward to disseminating clinically rooted information to keep health care providers well versed in treatment landscapes, with the greater goal of improving patient outcomes.”

Yale Cancer Center combines a tradition of innovative cancer treatment and quality care for patients. A National Cancer Institute-designated Comprehensive Cancer Center for more than 45 years, Yale Cancer Center is one of 51 such centers in the nation and the only one in Connecticut.

Yale Cancer Center is a collaboration between nationally and internationally renowned scientists and physicians at Yale School of Medicine and Smilow Cancer Hospital at Yale New Haven. This partnership enables the center to provide the best approaches for prevention, detection, diagnosis and treatment of cancer.

“Pharmacists serve as key members of multidisciplinary cancer care teams,” said Kevin Billingsley, M.D., MBA, FACS, chief medical officer at Yale Cancer Center. “Pharmacy Times® provides a special opportunity for our organization to communicate in a more direct and timely way with our pharmacy colleagues around the country.”

The Pharmacy Times® SAP program is a community of advocacy groups and medical associations and institutions that foster collaboration and an open exchange of information among trusted peers for the benefit of patients and their families. As part of this joint effort, Pharmacy Times® will work with Yale Cancer Center to inform and educate practicing pharmacists in Directions in Oncology Pharmacy® and Directions in Health Systems™ publications.

For more information about the Pharmacy Times® SAP program, click here.

About Pharmacy Times®

Pharmacy Times® is the industry-leading multimedia pharmacy network of community, health system, oncology and specialty pharmacy platforms, providing practical clinical and professional information that pharmacists can use every day in their practices when counseling patients and interacting with other health care providers. Each issue and the website contain articles and features covering industry trends, medication errors, drug interactions, patient education, disease state management, patient counseling, product news, pharmacy law and more. Additionally, Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Pharmacy Times® is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels.

About Yale Cancer Center and Smilow Cancer Hospital

Yale Cancer Center is one of 51 National Cancer Institute (NCI)-designated Comprehensive Cancer Centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital at Yale New Haven through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital care centers in Connecticut and Rhode Island. Smilow Cancer Hospital is accredited by the Commission on Cancer, a quality program of the American College of Surgeons. Comprehensive Cancer Centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention and innovative cancer treatment.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacy technician working in a pharmacy -- Image credit: sofiko14 | stock.adobe.com
Team of pharmacists -- Image credit: Jacob Lund | stock.adobe.com